Filters: Author is Paltiel, A David [Clear All Filters]
"Economic costs of influenza-related work absenteeism." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 6, no. 2 (2003): 107-15. Abstract
"Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example." Journal of acquired immune deficiency syndromes (1999) 46, no. 1 (2007): 78-90. Abstract
"The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: examining the RV144 trial results." Vaccine 29, no. 36 (2011): 6107-12. Abstract
"Scaling up circumcision programs in Southern Africa: the potential impact of gender disparities and changes in condom use behaviors on heterosexual HIV transmission." AIDS and behavior 15, no. 5 (2011): 938-48. Abstract
"Projected survival gains from revising state laws requiring written opt-in consent for HIV testing." Journal of general internal medicine 26, no. 6 (2011): 661-7. Abstract
"HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policies." Journal of acquired immune deficiency syndromes (1999) 51, no. 3 (2009): 310-6. Abstract
"The survival benefits of antiretroviral therapy in South Africa." The Journal of infectious diseases 209, no. 4 (2014): 491-9. Abstract
"Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 11, no. 1 (2008): 110-8. Abstract
"Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness." PloS one 9, no. 1 (2014): e85197. Abstract
"Social costs of robbery and the cost-effectiveness of substance abuse treatment." Health economics 17, no. 8 (2008): 927-46. Abstract
"Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patients." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S113-8. Abstract
"Cost-effectiveness of inhaled steroids in asthma: impact of effect on bone mineral density." The Journal of allergy and clinical immunology 117, no. 2 (2006): 359-66. Abstract
"Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma." Pediatrics 118, no. 2 (2006): e347-55. Abstract
"Cost advantage of dual-chamber versus single-chamber cardioverter-defibrillator implantation." Journal of the American College of Cardiology 46, no. 5 (2005): 850-7. Abstract
"Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines." Archives of internal medicine 162, no. 8 (2002): 921-8. Abstract
"Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection." The American journal of medicine 115, no. 8 (2003): 632-41. Abstract
"A Flow-Based Model of the HIV Care Continuum in the United States." Journal of acquired immune deficiency syndromes (1999) (2017). Abstract
"Reducing sexual violence by increasing the supply of toilets in khayelitsha, South Africa: a mathematical model." PloS one 10, no. 4 (2015): e0122244. Abstract
"The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening." Annals of internal medicine 145, no. 9 (2006): 646-53. Abstract
"The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis." PLoS medicine 11, no. 9 (2014): e1001725. Abstract
"Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients." Antiviral therapy 10, no. 1 (2005): 41-52. Abstract
"A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up." Chest 126, no. 6 (2004): 1875-82. Abstract
"Task force #2--the cost of prevention: can we afford it? Can we afford not to do it? 33rd Bethesda Conference." Journal of the American College of Cardiology 40, no. 4 (2002): 603-15.
"A novel approach to defining the relationship between lung function and symptom status in asthma." Journal of clinical epidemiology 55, no. 1 (2002): 11-8. Abstract
"Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume." Archives of internal medicine 169, no. 12 (2009): 1113-21; discussion 1121-2. Abstract
"Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal." PLoS medicine 6, no. 10 (2009): e1000173. Abstract
"Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 49, no. 10 (2009): 1570-8. Abstract
"Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans." Annals of internal medicine 154, no. 4 (2011): 217-26. Abstract
"Dengue vector control strategies in an urban setting: an economic modelling assessment." Lancet 377, no. 9778 (2011): 1673-80. Abstract
"Fact, fiction, and fairness: resource allocation under the Ryan White CARE Act." Health affairs (Project Hope) 25, no. 4 (2006): 1103-12. Abstract
"Expanded HIV screening in the United States: what will it cost government discretionary and entitlement programs? A budget impact analysis." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 13, no. 8 (2010): 893-902. Abstract
"The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 44, no. 8 (2007): 1115-22. Abstract
"Association between preference-based health-related quality of life and asthma severity." Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 92, no. 3 (2004): 329-34. Abstract
"Impact of site of care, race, and Hispanic ethnicity on medication use for childhood asthma." Pediatrics 109, no. 1 (2002): E1. Abstract
"Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: A model-based analysis in Côte d'Ivoire." Journal of acquired immune deficiency syndromes (1999) (2014). Abstract
"Home HIV testing: good news but not a game changer." Annals of internal medicine 157, no. 10 (2012): 744-6.
"Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs." Annals of internal medicine 145, no. 11 (2006): 797-806. Abstract
"Expanded screening for HIV in the United States--an analysis of cost-effectiveness." The New England journal of medicine 352, no. 6 (2005): 586-95. Abstract
"Price, performance, and the FDA approval process: the example of home HIV testing." Medical decision making : an international journal of the Society for Medical Decision Making 30, no. 2 (2010): 217-23. Abstract
"Paltiel Letter to the Editor." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2014).
"HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 48, no. 6 (2009): 806-15. Abstract
"Misinterpretation of HIV preexposure prophylaxis findings." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 59, no. 1 (2014): 139-41.
"Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US." HIV clinical trials (2015): 1945577115Y0000000009. Abstract
"The cost-effectiveness of treatment for varicocele related infertility." The Journal of urology 168, no. 6 (2002): 2490-4. Abstract
"Cost-effectiveness of HIV screening for incarcerated pregnant women." Journal of acquired immune deficiency syndromes (1999) 38, no. 2 (2005): 163-73. Abstract
"The clinical role and cost-effectiveness of long-acting antiretroviral therapy." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2015). Abstract
"Are we studying what matters? Health priorities and NIH-funded biomedical engineering research." Annals of biomedical engineering 38, no. 7 (2010): 2237-51. Abstract
"Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease." Journal of acquired immune deficiency syndromes (1999) 39, no. 1 (2005): 69-77. Abstract
"HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?" PloS one 9, no. 11 (2014): e113031. Abstract
"The lifetime medical cost savings from preventing HIV in the United States." Medical care 53, no. 4 (2015): 293-301. Abstract
